Clincosm LogoSign in Get a demo

gastric cancer

Showing 1 - 25 of 1,371
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in China (Capecitabine, oxaliplatin, Disitamab Vedotin)

Not yet recruiting
  • Gastric Cancer
  • Gastroesophageal Junction Adenocarcinoma
  • Beijing, Beijing, China
  • +10 more
Nov 23, 2023

Gastric/Colorectal Cancers

Not yet recruiting
  • Gastric Cancer
  • Colo-rectal Cancer
  • quantitative Real-time PCR
  • (no location specified)
Nov 27, 2023

Gastric Cancer, Multi-omics, Diagnosis Trial in Hangzhou (Without any intervention)

Active, not recruiting
  • Gastric Cancer
  • +2 more
  • Without any intervention
  • Hangzhou, Zhejiang, China
    Cancer Hospital of the University of Chinese Academy of Sciences
Nov 15, 2023

Gastric Cancer, Pancreatic Cancer, Solid Tumor Trial in Beijing (KD-496)

Not yet recruiting
  • Gastric Cancer
  • +2 more
  • KD-496
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Nov 15, 2023

Gastric Cancer, Colon Cancer, Rectal Cancer Trial in Wuhu (CEA-targeted CAR-T cells)

Recruiting
  • Gastric Cancer
  • +7 more
  • CEA-targeted CAR-T cells
  • Wuhu, Anhui, China
    The First Affiliated Hospital of Wannan Medical College
Nov 9, 2023

Gastric Cancer Trial in Xi'an (dietary supplement, biological, drug)

Recruiting
  • Gastric Cancer
  • Taurine
  • +3 more
  • Xi'an, Shaanxi, China
    Tang-Du Hospital
Nov 7, 2023

Gastric Cancer Trial (Analgesia nociception index-guided anesthesia, Standard anesthesia)

Not yet recruiting
  • Gastric Cancer
  • Analgesia nociception index-guided anesthesia
  • Standard anesthesia
  • (no location specified)
Nov 7, 2023

Gastric Cancer Trial in Xi'an (dietary supplement, biological, drug)

Recruiting
  • Gastric Cancer
  • Taurine
  • +4 more
  • Xi'an, Shaanxi, China
    Tang-Du Hospital
Nov 2, 2023

Esophageal Cancer, Gastric Cancer Trial in Worldwide (Surveillance protocol)

Not yet recruiting
  • Esophageal Cancer
  • Gastric Cancer
  • Surveillance protocol
  • Cologne, Germany
  • +12 more
Oct 29, 2023

GastroEsophageal Cancer, Gastric Cancer Trial in Tampa (Neratinib, Trastuzumab, Oxaliplatin)

Recruiting
  • GastroEsophageal Cancer
  • Gastric Cancer
  • Tampa, Florida
    Moffitt Cancer Center
Oct 25, 2023

Plasma Metabolic Biomarkers for Gastric Cancer Diagnosis

Recruiting
  • Gastric Cancer
  • Gastric cancer
  • Beijing, China
  • +3 more
Oct 26, 2023

Esophageal Cancer, Small Bowel Cancer, Gastroesophageal-junction Cancer Trial in Sacramento (Ablative local therapy)

Recruiting
  • Esophageal Cancer
  • +10 more
  • Ablative local therapy
  • Sacramento, California
    University of California, Davis
Oct 27, 2023

Gastric Cancer Trial (Laparoscopic and Endoscopic Collaborative Surgery (LECS))

Not yet recruiting
  • Gastric Cancer
  • Laparoscopic and Endoscopic Collaborative Surgery (LECS)
  • (no location specified)
Oct 26, 2023

Adebrelimab and Fruquintinib Combined With Paclitaxel/Albumin

Recruiting
  • Gastric Cancer
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute and Hospital
Oct 22, 2023

Adebrelimab and Fruquintinib Combined With Paclitaxel/Albumin

Recruiting
  • Gastric Cancer
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute and Hospital
Oct 22, 2023

Fruquintinib Combined With TAS102 for Advanced Gastric Cancer

Recruiting
  • Gastric Cancer
  • Fruquintinib, TAS102
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute and Hospital
Oct 22, 2023

Multivisceral Resections for Locally Advanced Gastric Cancer

Completed
  • Gastric Cancer
  • Extent od surgical resection
  • Kraków, Małopolska, Poland
    First Department of Surgery, Jagiellonian University Medical Col
Oct 25, 2023

Aims to Assess Consistency of Clinical Efficacy in Gastric

Recruiting
  • Gastric Cancer
  • Organoids
    • Shenyang, Liaoning, China
      Phase I Clinical Trials Center Of The First Hospital of China Me
    Oct 20, 2023

    Gastric Cancer Trial in Shanghai (NK510, Tislelizumab,atezolizumab or Trastuzumab)

    Enrolling by invitation
    • Gastric Cancer
    • NK510
    • Tislelizumab，atezolizumab or Trastuzumab
    • Shanghai, China
      Shanghai Tenth People's Hospital
    Oct 22, 2023

    Gastric Cancer, Gastroesophageal-junction Cancer, Advanced Cancer Trial (TST001, CapOx or mFOLFOX6 and NIVO or (Substudy)

    Not yet recruiting
    • Gastric Cancer
    • +2 more
    • TST001, CapOx or mFOLFOX6 and NIVO or (Substudy) TST001, Oxaliplatin and capecitabine or 5-fluorouracil (5-FU)
    • Placebo CapOx or mFOLFOX6 and NIVO or (Substudy) Placebo, Oxaliplatin and capecitabine or 5-fluorouracil (5-FU)
    • (no location specified)
    Oct 16, 2023

    Gastric Cancer Trial (Fruquintinib)

    Not yet recruiting
    • Gastric Cancer
    • (no location specified)
    Oct 17, 2023

    Advanced Solid Tumor, CDKN2A, NSCLC Trial (Milademetan, Atezolizumab)

    Withdrawn
    • Advanced Solid Tumor
    • +9 more
    • (no location specified)
    Oct 16, 2023

    Solid Tumor, Adult, Solid Tumor, Gastric Cancer Trial in Seongnam, Seoul (PB101)

    Recruiting
    • Solid Tumor, Adult
    • +5 more
    • Seongnam, Korea, Republic of
    • +2 more
    Oct 11, 2023

    Gastric Cancer, HER2-low-expressing Gastric Cancer Trial in Shanghai (Disitamab Vedotin, Toripalimab)

    Recruiting
    • Gastric Cancer
    • HER2-low-expressing Gastric Cancer
    • Shanghai, China
      Shanghai East Hospital
    Oct 9, 2023

    Gastric Cancer Trial in Chang chun

    Not yet recruiting
    • Gastric Cancer
      • Chang chun, Ji Lin, China
        the First Hospital of Jilin University
      Oct 6, 2023